News Focus
News Focus
icon url

Investor2014

11/14/21 8:52 AM

#335938 RE: couldbebetter #335936

Yes that's what investors do i.e. leave the decisions to the CEO rather than message boards posts - including mine.

This of course assuming one has confidence in one's own throrugh and up-to-date due dillingence into the company's managment, drug pipeline, financials, potential and timing.

Ah yes that last timing thing seems to be a main concern with Anavex, but not sure if in the end timing is the most important criteria for evaluating ultimate success.

The longer we wait the sooner we will be sure whether or not absolutely great $AVXL news is just around yet another corner.
icon url

frrol

11/14/21 9:41 AM

#335941 RE: couldbebetter #335936

Biotech execs "know exactly what they have": an experimental drug. People speculating carelessly in a biotech stock assume it is a drug that surely works, which is false.

There's no 'inside knowledge'. It's why we do clinical trials. To be a good biotech investor, you watch for their results. Never assume "we got this". The biotech graveyard is littered with the bones of the foolish or inexperienced.
icon url

bas2020

11/14/21 11:25 AM

#335952 RE: couldbebetter #335936

Agree with your position and logic... though not your metaphor.

very hard road to hoe



I think you meant "row to hoe", unless you meant "road to ho"... which would be more applicable to SAVA and Remi ;-)